This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Respiratory Coronavirus (CRCoV) Nucleoprotein Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine respiratory coronavirus nucleoprotein. It is affinity purified by protein A. It can be applied to ELISA, IFA and WB assays of canine respiratory coronavirus nucleoprotein.
Specifications
Target Information
Canine respiratory coronavirus (CRCoV) is a pathogen that can lead to respiratory infections in dogs. The nucleoprotein (NP) of CRCoV is an integral component of the virus, playing a central role in the packaging of the viral RNA genome into the nucleocapsid. The NP is involved in various steps of the viral replication cycle and is essential for the assembly of new virions. The NP is a potential target for antiviral therapies against CRCoV due to its indispensable function in the viral life cycle. Inhibiting the NP could disrupt the replication and assembly processes, thereby limiting the spread of the virus within the host. Additionally, the NP is an immunogenic protein that can stimulate an immune response, making it a candidate for diagnostic assays and vaccine development.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 24 months). Avoid exposure to light. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Colitti, Barbara, et al. "Pulmonary fibrosis in a dog as a sequela of infection with Severe Acute Respiratory Syndrome Coronavirus 2? A case report." BMC veterinary research 18.1 (2022): 111.